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One of the most interesting scientific challenges of our time has been to understand the 
spectrum of oncogenic changes necessary to commit normal cells to a neoplastic 
life-style. On the molecular level, this enigmatic quest centers upon our understanding 
the essential ingredients needed to control cell growth (and its coordinate processes), as 
well as to maintain the normal differentiated pattern of expression for specific genes. 
Another, perhaps simpler, approach to this difficult challenge would be to examine the 
genetic changes resulting from the introduction of a known acute retroviral transform- 
ing sequence capable of eliciting a malignant cellular phenotype in vitro and neoplastic 
disease in vivo. Through the application of the powerful technique of recombinant 
technology application in the study of model retrovirus systems, the precise DNA 
sequences responsible for cellular transformation have been identified and studied. 
Thus, the employment of acute retroviruses as tools to identify a select cohort of genes 
capable of malignant transformation has been most fruitful. More important, from this 
study came a realization that this category of genes, the viral oncogenes, were capable 
of establishing and maintaining the transformed state, as well as the recognition that 
these genes were derivatives of a limited population of normal cellular genes, the 
proto-oncogenes, that can be captured and modified by the viral transduction process. 
These homologous genes, now numbering several dozen, are  found distributed in the 
genomes of almost all vertebrates and of some invertebrate species, as well as of a few 
more primitive single-cell species. 
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Some general conclusions have been evolving from the study of these viral 
oncogenes and their normal cellular homologs, namely, that the transforming variants 
are damaged, frequently truncated versions of the normal cellular proto-oncogenes.' 
Thus, this avenue of study provides scientists and oncologists with some direction and 
serves to focus research at many levels. These investigations, be they biochemical, 
genetic or clinical have pointed to common cellular denominators implicating these 
oncogenes and proto-oncogenes and their products in certain critical processes in which 
they may be involved.2 Added to these investigations is the cumulative evidence that 
these oncogene homologs are located at critical sites on human chromosomes. These 
loci may be subject to nonrandom chromosomal aberrations and thus be involved in 
quantitative or qualitative changes associated with human neoplasia and other 
diseases.' 
Studies in our laboratory have centered on the use of retroviruses as tools to 
investigate avian acute leukemia virus transforming genes and their normal cellular 
counterparts. As a result of these studies, we have come to realize that specific viral 
oncogenes like those belonging to the avian erythroblastosis virus, E26, not only 
contribute significantly to a growing body of information related to that class of 
conserved cellular genes that may be important in tumorigenesis, but may also be 
functionally important in cell growth and, as such, relevant to other human diseases.' 
The transforming sequences of the avian acute leukemia virus, E26, contain two 
distinct oncogenes, v-mybE and v-ets, fused together with segments of the viral 
structural genes, A-gag and A-env, to constitute the 5.7-kilobase (kb) genome of this 
replication-defective retrovirussB6 (FIG. 1). 
The E26 virus induces both myeloblastic disease and erythroblastosis in vivo. The 
myeloid oncogenic property that the E26 virus and avian myeloblastosis virus (AMV) 
share in common is thought to be due to their common transduction of myb d i n g  
domains. The erythroblastosis pathology of E26 virus, on the other hand, may be due to 
the presence of the unique v-ets domain or perhaps to a synergistic effect of both 
oncogenes. The nucleotide sequence of a 2.5-kb ets-containing region of E26 DNA 
reveals a contiguous gag-myb-ers open reading frame encoding a 135-Kd protein, 
p135, a product found in E26 viral-transformed  cell^.^*^ 
To study the genetic organization and origin of the ets oncogene, our laboratory has 
cloned and studied the molecular details of the proto-ets gene originating from the 
avian host (i.e., the chicken), as well as compared these proto-ets genes in a variety of 
other species of animals, including man.* To facilitate our investigations on the 
comparison of chicken proto-ers genes, with the viral ets genes, overlapping clones were 
isolated and digested with different restriction enzymes and then hybridized with 
specific segments of v-ets probes and aligned. Nine presumptive exons were thus 
defined by their homology to v-ets, each exon delineated by consensus splice-acceptor 
and splice-donor sequences. These cellular exons ranged in size from 82 to 257 base 
pairs, while the introns are seen to be quite variable, ranging from 0.1 kb to greater 
than 40 kb. The v-efs homologous chicken sequences are seen to be spread over 60 kb of 
genomic DNA, making it one of the most dispersed proto-onc genes characterized thus 
far (FIG. 2). As expected, since the chicken is the retroviral host organism, there is a 
very high conservation of the majority of ets sequences found in the virus; all but three 
nucleotides are unchanged from chicken to virus. Moreover, the chicken and the viral 
genes are not coterminaL9 However, this observation is consistent with our data 
obtained from human genomic and cDNA clones demonstrating that the human ets-2 
and v-ets genes are not coterminal." 
Using segments of the v-ets oncogene as probes, we have been able to identify 
proto-ets sequences in the human genome, as well as in the genome of other mammals 
(feline and murine). In humans there are two distinct v-ers homologous loci, Hu-ets- 1 
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and Hu-ets-2. These human loci were found to be discontiguous unlike that of chicken 
and avian E26 virus except for a small region of overlap." On the basis of structural 
organization and molecular sequence comparisons, we have defined the 5' portion of 
the viral ets oncogene as ets-1, and the 3' portion of the viral ets oncogene as ets-2. 
These proto-ets domains in mammals map to separate loci on homologous, but 
distinctly different chromosomes. Thus, the 5' v-ets homologous region defined above 
locates in man (i.e., human proto-ets-1 gene [Hu-ets-1] ) on chromosome 1 1; its feline 
and murine counterparts locate on chromosomes (f)D1 and (m)9, respectively. The 3' 
v-ets homologous region similarly locates in man (i.e., human proto-ets-2 gene 
[Hu-ets-21) on chromosome 21, while the feline and murine homologs are on 
chromosome (f)C2 and (m) 16, respectively. Each of the efs genes characteristically 
belong to homologous syntenic groups in Mammalia with respect to other genetic 
markers (FIG. 3)." 
Scrutiny of the nucleotide sequences of the cloned human proto-ets sequences with 
their viral ets homolog reveals a striking level of conservation. The Hu-ets-1 and 
Hu-ets-2 genes, respectively, possess a 98% and 95% homology with their viral 
counterparts, comparing a t  the amino acid level. This homology would place these 
genes among those highly conserved between cellular and viral oncogene sequences. 
Most surprising, however, has been our observations on the cloned els-2 homologous 
sequences in Drosophila; this homolog, containing only the last two exons of ets, shows 
over a 90% conservation at  the amino acid level compared with the Hu-ets-2 gene-a 
I 
E26 RNA (5.7 Kb) 5'1 Agag I myb I ets I AWIV 1311 
lkb 
FIGURE 1. Genomic organization of the avian acute transforming virus, E26. 
remarkable level of conservation; also the highest thus far noted for any proto- 
oncogenes so widely separated on the evolutionary scale (FIG. 4).12 
Our laboratory has been able to determine that both the human ets-1 and ets-2 loci 
are transcriptionally active and are differentially expressed; the Hu-ets-1 gene is 
transcribed as a single 6.8-kb mRNA, while the Hu-ets-2 gene is expressed as three 
distinct species of RNA, sized 4.7, 3.2 and 2.7 kb. By contrast, the chicken c-ets 
mRNA is five times more complex (7.5 kb) than the viral ets genomic R N A  (1.5 kb). 
Interestingly, the viral ets contains in its 5' domain, the v-ets-1 region, 224 
nucleotides not found transcribed in chicken thymus. Thus, not only has the E26 virus 
captured a much smaller portion of the chicken ets gene, but it has also transduced a 
substantial portion of cellular noncoding sequences that are  now able to be incorpo- 
rated into the E26 viral-encoded product.13 These molecular events, in addition to the 
carboxy terminal differences noted above, probably have important functional implica- 
tions for the retroviral transforming protein, as well as its biochemical role in cellular 
transformation. 
As stated above, the products of the mammalian ets-1 and ets-2 genes appear to be 
differentially expre~sed '~  and we shall present evidence later in this report that their 
encoded protein products are  localized predominantly in separate subcellular compart- 
ments." Specifically, the human ets- 1 gene-encoded protein seems to locate preferen- 
tially in the cytoplasm, while the human ets-2 gene-encoded protein appears in the 
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nucleus. It is known that a number of proto-oncogene products, particularly of the 
nuclear family, have been implicated in cellular systems as regulators and effectors of 
proliferation. 
To investigate the possibility that the ets genes may be involved in such growth- 
related processes we studied its expression in a variety of murine tissue, including 
germ-line tissue (testis). The expression of ets- 1 was much higher in cells and tissue of 
hematopoietic origin than in other tissue, including hepatic tissue. The murine 
expression of ets-1, as characterized by multiple species of mRNA, 5.3,4.0,2.5 and 2.0 
kb in size, was found to be actively transcribed in both young and old thymus tissue. By 
contrast, the product of the murine ets-2 gene, characterized by a 3.5-kb transcript, 
was preferentially expressed in a variety of proliferating young tissue by contrast to less 
proliferative older tissue. This relative difference was most clearly evident in testis 
tissue, where ets-2 mRNA synthesis was maximal in 8-day-old preparations, compared 
to older (42-day) germ-line-derived samples (FIG. 5). This observation suggested that 
the proliferative state of the tissue may be relevant to the expression of ets-2. In fact, 
for these age groups, even for the exception noted, the abundant ets-2 expression in 
thymus tissue tended to prove the rule, since thymocytes are normally in a highly 
proliferative state. By contrast, there was significant lower expression of ets-2 in 
terminally differentiated adult brain, liver, kidney, lung and heart tissue, which were 
compared with appropriate controls, using an a-tubulin gene probe. Thus, it appeared 
from these data that the ets genes are differentially expressed and subject to variable 
regulation in proliferating tissue (FIG. 5).l4.l6 Studies on the expression of ets-1 and 
ets-2 gene-encoded protein also substantiated these observations (FIG. 6). Antisera 
raised against an ets-2 domain specific oligopeptides and bacterially-expressed ets 
proteins detected two ets gene proteins (56 KDa and 30 KDa), which appeared to 
correlate very well with the ets-2 mRNA expression observed in young and adult 
thymus. The thymus is the only adult tissue examined that had both ets-2 RNA and 
protein expressed at  a high level when compared to nonhematopoietic tissue. Unlike 
the 56-KDa ets-2 protein, there was a selected species not detected by immunoprecipi- 
tation, suggesting that this 30-Kd protein may represent some cross-reacting species. 
To further elucidate the linkage of ets-2 gene expression with cellular proliferation, 
we studied hepatically regenerating tissue as  a model in-vivo system. It is known that 
when two thirds of the liver mass is removed by surgery in the mouse,17 the remaining 
liver cells proliferate and organ mass and function is completely restored within 5 to 6 
days posthepatectomy.'* FIGURE 7 depicts a result of our Northern transfer analysis of 
poly A-selected RNA obtained a t  various times postpartial hepatectomy. Data shows 
clearly that the ets-2 mRNA peaks 4 hrs following surgery, and returns to basal levels 
within 24 hrs. Densitometric scanning studies of the 4-hr sample of ers-2 mRNA, 
following partial hepatectomy, shows a 10-fold increase above basal levels found in 
sham controls or in adult liver tissue. It should be kept in mind that these are  minimal 
values, since the entire liver was used to prepare R N A  rather than the specific 
regenerated tissue. Clearly, the induction of ets-2 mRNA is due to the partial 
hepatectomy, and not the stress induced by surgery, since only basal levels of ets-2 
mRNA can be detected in sham control samples. The amount of R N A  applied in each 
lane was the same, since there were equivalent levels of rRNA present in all samples 
tested. 
During the course of liver regeneration DNA synthesis peaked a t  48 hrs following 
surgery, consistent with other published reports;I7 thus, the maximal expression of 
ets-2 occurring at  4 hrs after hepatectomy is well before that of DNA synthesis. 
Hepatic ets-1 expression, unlike that of ets-2, was not detected following partial 
hepatectomy at  any of several time points spanning one round of DNA replication, 
further corroborating that these genes are differentially expressed. 
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FIGURE 5. Distribution of efs mRNA in Young ( Y )  and Adulf (A) tissues; ( A )  Ethidium 
bromide stained pattern of the residual rRNA. Three micrograms of p l y  A+ RNA was 
fractionated on denaturing agarose min-gel after the electrophoresis fractionated RNAs were 
stained with ethidium bromide. (B and C) Northern blot analysis of ers mRNA. Twenty 
micrograms of p l y  A+ RNA from Young (5 to 10 day old) and Adulr ( 5  to 6 week old) tissues 
were fractionated and Northern blots were probed with human ers-I-specific probe (B) or with 
mouse ers-2 probe (C) as described in the text. The ers-1 and ers-2 transcripts are shown by 
arrows. Minor transcripts are indicated by dashes. BRL RNA ladder was used as standard 
RNA markers and their sizes (kb) are shown on the leff  hand side. 
To arrange the induction of ets-2 mRNA in an ordered sequence of expression 
relative to other genes known to be involved in cell proliferation, we examined the 
kinetics of expression of several select genes. Specifically, we probed several proto- 
oncogenes: rnyc andfos of the nuclear family; mht, erbB of the protein kinase family; 
and sis of the growth factor family. Also, we selected several non-oncogenes 
representing the housekeeping family, actin, tubulin, and those of a stress-related 
family, the heat shock protein, and a metallothionein protein. The ets-2 mRNA levels 
increased 10-fold in 4 hrs, returning to basal levels by 24 hrs; whereas the kinetics of 
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FIGURE 6. Western blot analysis of ets-2 protein in Young ( Y )  and Adult (A) tissues. Two 
milligrams (wet/wt) tissues were solubilized in sample buffer and size fractionated on 10% 
polyacrylamide SDS gels. Western blots were processed in the absence (top panel) or in the 
presence (bottom panel) of cognate peptide as described in the text. The position of the 
56-Kd putative ets-2 protein is indicated by the arrow. Standard molecular weight markers 
are shown on the feft hand side. 
myc and rusH mRNA induction is notably different from that of ets-2. Specifically, the 
m y  RNA level increased 3- to 4-fold after 2 hrs and returned to basal level by 8 hrs. 
By contrast, rusH mRNA increased 2-fold and remained elevated even after 48 hrs. 
The proto-oncogenes fos, mht, erbB or sis-specific transcripts were not detected at  
different time points examined during hepatic regeneration. Note, however, that the 
metallothionein messenger RNAs increased more than 100-fold in both sham-operated 
and hepatectomized animals, reflecting the stress imposed by surgery. Actin mRNA, 
too, was induced, but only 10-fold, 4 hrs following partial hepatectomy; this wurse of 
induction was different from the a-tubulin mRNA, which increased 2- to 4-fold after 
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48 hrs. Failure to detect expression of the proto-oncogene, c-fos, which is transiently 
expressed, was expected, since our earliest time point sampled was 2 hrs posthepatecto- 
my; this is a time well past the known maxima of c-fos ind~ct ion . '~  Collectively, these 
data are in agreement with the sequential expression of nuclear proto-oncogenes that 
are known to induce during the transition from Go&, phase of the cell cycle following 
partial hepatectomy." 
Like other nuclear proto-oncogene mRNAs, cycloheximide was found to superin- 
Partial 
Hepatectomy -
i! 
3 
Partial 
H epa tec tomy -
E m r 
v) 
- a-Tubulin 
- P-Actin 
-HSP 
-MMT 
FIGURE 7. Gene expression during liver regeneration. Fifteen micrograms of p l y  At  
RNA from adult liver, sham control livers, and livers from partially hepatectomized animals 
were size fractionated and filters were probed sequentially with mouse ets-2, human ets-I, 
human my. v-rm", a-tubulin, @-actin, heat shock protein (HSP) and mouse metallothion- 
ein (MMT) probes. Transcripts detected by these probes are indicated on the right hand 
side. 
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duce the level of ets-2 RNA by more than 15-fold, as well as stabilizing the ets-2 
message. Partial hepatectomy amplified (20- to 40-fold) the effect of this ets-2 
expression, which was not observable for the ets-1 mRNA. Myc, fos and ornithine 
decarboxylase (a marker for cell proliferation) also shared the same expression pattern 
as the ets-2 gene. Collectively, these data help establish that the ets-2 gene is a member 
of a proliferative gene family, and one that is subject to differential regulation and 
expression in proliferating hepatic tissue. Our data implicate the ets-2 gene as a 
member of the family of nuclear proto-oncogenes that is normally expressed during the 
early phase of hepatic regeneration and can be characterized by the following 
sequential expression, fos -- myc --- ets-2 ---. We do not know as yet if 
these genes are obligatorily expressed in this particular sequence, or if the gene 
transcripts are processed at different rates and thus appear so ordered. We do know, 
however, that during hepatic regeneration the transcription of the ets-2 proto-oncogene 
does not require de-novo protein synthesis. 
To summarize, our results on the studies of ets RNA in mice suggest that in murine 
liver both ets-1 and ets-2 gene expression is differentially regulated; that the ets-2 gene 
transcription is inducible by hepatectomy and its expression is similar to the pattern of 
expression noted for other nuclear proto-oncogenes, fos and myc. It logically follows 
that the ets-2 gene product may be associated with the transition of cells from Go to GI 
phase of the cell cycle and this involvement is certainly consistent with the roles 
postulated for other nuclear proto-oncogenes. 
We have recently presented information identifying the products of the two human 
ets genes and their subcellular location.lso2' To accomplish this study, we developed 
antibodies specific for ets-I and ets-2 domains. Another antibody was prepared using a 
synthetic oligopeptide derived from the predicted amino acid sequences of the ets 
common domain; a portion of this region has been highly conserved in a variety of 
species, ranging from Drosophila to All of these antibodies are described in 
the legend of FIGURE 8. 
We established that these three antibodies reacted specifically with ets proteins by 
immunoreactive studies using extracts of transfected NIH3T3 cells infected with a 
murine/avian recombinant retrovirus construct containing the gag-myb-ets region of 
the E26 virus. The [ ''S]-methionine-labeled extracts of these cells were each immuno- 
precipitated using the three different antibodies. In all three experiments the antibod- 
ies precipitated the 135-KDa ets-containing fusion protein (FIG. 8, lanes 1, 3 and 5 ) .  
Moreover, precipitation of this v-ets-encoded protein was specifically blocked by an 
excess amount of the respective peptide-antigen (FIG. 8, lanes 2 and 4). The p135 
fusion protein was found only in transfected cell extracts and was also recognized by 
sera prepared against the avian retroviral gag protein. There is additional evidence, 
FIGURE 8, showing that these antibodies react with efs-specific sequences, since the 
ets-1-specific antibody also reacted with a v-ets-1 protein expressed in bacteria (FIG. 8, 
lane 6), and the ets- 1-ets-2 common domain antibody detected a bacterially-expressed 
ets-2 protein product (FIG. 8, lane 8). Both reactions were immunospecific, since excess 
peptide totally competed the precipitation of the respective ets proteins (FIG. 8, lanes 7 
and 9). 
Having reported previously that ets-1 and ets-2 domains are contiguous in the 
avian genome," we had to determine whether the ets-1 and ets-2 antibodies are able to 
detect a singular protein in chicken tissue, using for this purpose [ ?3]-methionine- 
labeled chicken thymus cells known to express high levels of ets-mRNA." Not 
surprisingly, antibodies against the ets-1 domain and efs-1-ets-2 common domain also 
immunoprecipitated chicken efs-1-ets-2-encoded protein (FIG. 8, lanes 10 and 12). 
To identify and characterize the human proteins derived from the ets-1 and ets-2 
loci, we have utilized cell lines expressing high levels of either ets-1 or ets-2 mRNA (N. 
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Bhat, unpublished  observation^).'^ For example, [ 3’S]-methionine-labeled Daudi cells, 
the Burkitt lymphoma cell line, was employed to detect the human ets-1 grotein, with 
our ets-I-specific antibody. As can be seen, a prominent 51-KDa protein was detected 
(FIG. 9, lane I ) ,  which was also detected using the common ets-1-ets-2 domain 
antibody (FIG. 9, lane 3). However, the antibody derived from the ets-2 region does not 
precipitate the p51 ers-1 protein (FIG. 9, lane 5). 
1 2 3 4  5 6 7  0 9  10 11 12 13 
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FIGURE 8. Specificity of the ers antibodies. Antibody A (ets-1-specific), Antibody B 
(ers- 1 -ets-2-specific) and Antibody C (ers-2-specific) have been described.”.” In lanes I 
rhrough 5. the p135 gag-myb-ers protein was immunoprecipitated from extracts of NIH3T3 
cells transfected with the murine/avian recombinant retrovirus construct (Yuan, Q., Blair, 
D., Papas, T., unpublished results) that were labeled with [”Slmethionine (100 pCi/ml, I 
h )  and lysed using RlPA buffer (50 mM Tris-HCI, pH 7.5, 150 mM NaCI, 0.1% SDS, 1 .O% 
Triton X-100,0.5% deoxycholate, 0.1 mM EGTA, 1.0 mM EDTA, 0.4 mM phenylmethyl- 
sulfonyl fluoride (PMSF), 0.01 mM Na-p-Tosyl-L-lysine chloromethyl ketone (TLCK), 0.1 
mM N-Tosyl-L-phenylalanine chloromethyl ketone (TPCK)). The lysate was clarified by 
ultracentrifugation (100,000 x g, 30 min) and subjected to immunoprecipitation by the 
rabbit antibodies prepared against the synthetic oligopeptide derived from a viral ers- 1 
domain (Antibody A) (lanes I and 2). the antibody directed against the common ers-1-ers-2 
domain (Antibody B) (lanes 3 and 4). and the antibody directed against the ers-2 domain 
(lane 5). Competition is shown by preincubation with the ers-1 (lane 2) or ers-I-ers-2 (lane 
4) peptides. Immunoprecipitates were fractionated by sodium dodecyl sulfate-polyacryl- 
amide gel electrophoresis (SDS-PAGE) ( 1  2.5% acrylamide) and detected by fluorogra- 
phy.”.” The arrow indicates the pl35 viral protein. In  lanes 6 through 9 portions of the viral 
ers-1 and human ers-2 proteins expressed in E. coli were detected by imm~noblotting.’~ A
portion of the viral ets-1 domain (nucleotide 666-1334,’) and a cDNA clone of the human 
ers-2 gene (cDNA-14,’) have been expressed in E.  coli and are partially purified.” The viral 
ers-1 (lanes 6 and 7) or human ers-2 proteins (lanes 8 and 9) were probed by Antibody A 
(lanes 5 and 6) or Antibody B (lanes 7 and 8). Competition is shown by preincubation of 
antibodies with their corresponding peptide antigens (lanes 7 and 9). Arrows indicate the 
expressed viral ers-1 (lane 6) or human ets-2 protein (lane 8). In lanes 10 through 13 the 
chicken ers protein is immunoprecipitated from [’5S]methionine-labeled thymus cells 
prepared from 2-week-old chickens as described. Competition is shown for Antibody A 
(lanes 10 and 11) and Antibody B (lanes 12 and 13) by preincubation with the ers-1 peptide 
(lane 1 1 )  or ers-1-ers-2 peptide (lane 13). Relative mobilities of standard proteins are shown 
on the sides of each panel. 
Similarly, to characterize the human ets-2 protein, we utilized the human 
tumor-derived cell line, COLO 320 DM. In this study, a 56-KDa protein was 
specifically immunoprecipitated (FIG. 9, lane 11) from labeled cell lysates using the 
ets-2-specific antibody. In parallel experiments the 56-KDa protein was also able to be 
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precipitated with common ets-I-ets-2 domain antibody (FIG. 9, lane 8). However, it 
should be noted that the ets-1 specific antibody does not precipitate this 56-KDa efs-2 
protein (FIG. 9, lane 6). We can thus conclude that each of these cell lines contain 
distinct efs-l and efs-2 proteins, and that both these proteins can be recognized by 
antibodies prepared against the common ets- I-efs-2 domain. Moreover, antisera to a 
200K - 
93K - 
69K - 
6rs-L 
46K - 
1 2 3 4 5 6 7 8 9 1 0 1 1  
ets-2 - 
30K - 
FIGURE 9. lmmunoprecipitation of human ers-l and ers-2 proteins. [%]methionine- 
labeled lysates from the human Burkitt lymphoma cell line, Daudi (lanes 1 through 5 )  or the 
human COLO 320 DM cells (lanes 6 through 1 1 )  were immunoprecipitated by Antibody A 
(lanes 1, 2, 6 and 7).  Antibody B (lanes 3, 4. 8 and 9), Antibody C (lanes 5 and 11) or 
Antibody C pre-immune serum (lane 10). For competition, Antibody A and Antibody B were 
incubated with the ers-1 or ers-I-ers-2 peptides (lanes 2, 4. 7 and 9). The samples were 
adjusted to 2 x lo7 CPM (TCA insoluble ['5S]methionine with RIPA buffer, immunopreci- 
pitated and analyzed by SDS-PAGE and fluorography. The arrows indicate the human ers-l 
(lanes 1 and 3) or the human ers-2 (lanes 8 and 1 1 )  proteins. 
domain unique to efs-2 recognized only efs-2 protein in human cell extracts and not the 
efs-l protein, while antisera to an ets-l unique domain recognized only the ets-l 
protein in human cell extracts. 
Given the above observations, we felt it important to establish that the proteins 
PAPAS et al.: ets GENES 185 
immunoprecipitated by the different ets-Zspecific antibodies were similar; this 
analysis was performed first by one-dimensional peptide mapping using the V-8 
protease technique, which showed these maps to be essentially identical (data not 
shown). To demonstrate that this protein does contain an ets-2-related sequence, we 
employed a two-dimensional peptide-map analysis of the purified ”S-labeled ets-2 
protein from COLO 320 cells and compared it to the ets-2 domain product expressed in 
an E. roli vector. I n  these studies we found 10 polypeptides shared in common with the 
human p56 protein and the bacterially expressed ets-2 protein.” This observation 
provided direct evidence that the human p56 protein we analyzed shared peptides in 
common with the authentic ets-2-encoded protein expressed in bacteria. 
As an approach towards identifying specific functions of the two distinct human ets 
proteins, we fractionated the ets-1 and ets-2 expressing cells, P3HR-I and COLO 320 
DM, respectively, into subcellular components. Fractionation of [ ?S]-methionine- 
labeled COLO 320 DM cells followed by immunoprecipitation, indicated that the 
human ets-2 p56 protein (large arrow, Fig. IOC, lanes 1 and 7) located exclusively in 
the nucleus. Other proteins immunoprecipitated (small arrows, Fig. IOC, lanes I and 
7) have been characterized by two-dimensional peptide mapping analysis and shown to 
share homology with the ets-2 p56 protein. It should be pointed out that under the 
conditions employed for fractionation of COLO 320 DM cells, the ets-2 protein was 
more tightly associated with the nuclear fraction than the “nuclear-associated” c - m y  
gene p r o d ~ c t . ~ ’  
Similar experiments on the ets- 1 protein were performed using [ %I-methionine- 
labeled fractionated human P3HR- 1 lymphoid cells. These studies clearly demon- 
strated that the 51-KDa ets-1 protein, unlike the ets-2 protein, is located exclusively in 
the cytoplasm (FIG. IOB, lane 3). To compare this human cellular localization of the 
ers protein to that of the avian cells, we labeled chicken thymus cell and fractionated 
them as described (FIG. 10, legend). Immunoprecipitation of the avian cell lysates 
shows that a 51-KDa protein, present in  total cell lysates (FIG. IOA, lane 2), was 
equally distributed between the nuclear and cytoplasmic subfractions. This study 
indicated that unlike the human protein where the separated products have an ets-l 
domain that enabled it to localize to the cytoplasm, and an ets-2 domain that enabled it 
to localize to the nucleus, the avian ets protein containing both the efs-l and ets-2 
domains is distributed between the cytoplasm and nucleus. 
The human 51-KDa and the 56-KDa proteins described have been demonstrated in 
our laboratory to be the products of the human ets-1 and ets-2-encoded domains, 
respectively. Localization of these proteins, indicate different intracellular compart- 
ments for each of these human ets-encoded gene products. These segregated subcellu- 
lar locations suggest further that each of these gene products performs a different 
function. 
An examination of the putative amino acid sequences of the ets-2 gene reveals a 
protein domain containing a region of basic amino acid residues (gly-lys-arg-lys- 
asn-lys-pro-lys),” which is essentially similar to the amino acid residues of the nuclear 
transport signal of the large tumor antigen of simian virus 40 (pro-lys-lys-lys- 
arg-lys-Val), as well as to that of the T-antigen of polyoma virus (val-ser-arg- 
lys-arg-pro-arg-pro). It should be pointed out that for nuclear localization signals thus 
far reported, there is no unique sequence of amino acids specifying nuclear placement; 
rather there appears to be a sequence of residues encoding a cluster of positively 
charged amino acids sandwiched between a proline residue and other nonpolar amino 
acids.24 This signal region in the ets-2 domain may, in fact, prove to be functionally 
significant for different organisms. It is evident that in higher organisms like 
mammals, where the ets-l and ets-2 domains are separate, each domain remains free 
to partition to its unique intracellular location. In the chicken, however, where the ets- 1 
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FIGURE 10. Subcellular localization of the chicken ets. human ets-l and human ers-2 
proteins. (A) Thymus cells prepared from 2-week-old chickens were labeled with [?S]methio- 
nine (200 fiCi/ml. 1 h) and after washes in cold phosphate buffered saline, the cells were 
gently homogenized in isotonic low salt buffer (20 mM HEPES, 0.25 M sucrose, 5 mM KCI, 5 
mM MgCI,, 0.5% NP-40, 0.1% sodium deoxycholate, 1.0% aprotinin, 0.4 mM PMSF, 0.01 
mM TLCK, 0.1 mM TPCK) and nuclei were pelleted by centrifugation at 1000 x g for 5 min 
at 4OC. The crude-cytoplasm was further fractionated by ultracentrifugation (100,000 x g) 
and the clarified cytoplasm and the membrane pellet were obtained. The nuclear pellet was 
washed once with the isotonic low salt buffer, after centrifugation at  1000 x g the nuclear 
wash fraction and the crude nuclei were obtained. The lysis of cells and nuclear isolation were 
monitored by phase-contrast microscopy. After ultracentrifugation, each fraction was 
adjusted to RlPA buffer conditions, and extracts (equivalent to 5 x lo’ cells) were 
immunoprecipitated with Antibody 9. Immunoprecipitation of the total cell extract (Panel A, 
lanes 1 and 2). cytoplasmic compartment (lane 3). membrane compartment (lane 4) and 
nuclear compartment (lane 5 )  are shown. Completion of Antibody B with the ers-I-ers-2 
peptide is in lane 1, and the arrow indicates the chicken ets protein. (B) Similarly, the P3HR-I 
cells were fractionated. The total extract (lanes 1 and 2), the cytoplasmic compartment (lanes 
3 and 4), the membrane compartment (lanes 5 and 6) and nuclear component (lanes 7 and 8), 
each representing 5 x lo6 cells, were immunoprecipitated with Antibody A. The competition 
with the ets-l peptide is shown in lanes 2.4.6 and 8 and the arrow indicates the ers-1 protein. 
(C) The human COLO 320 DM cells were fractionated. as above. The total extract (lanes 1 
and 2), cytoplasmic compartment (lanes 3 and 4), membrane compartment (lanes 5 and 6) 
and nuclear compartment (lanes 7 and 8). each presenting 5 x lo6 cells, were immunoprecipi- 
tated with Antibody 9. Competition with the ets-I-ets-2 peptide is shown in lanes 2.4.6 and 8 
and the arrow indicates the ers-2 protein. 
and ets-2 domains are in the same protein, the localization of the ets gene product may 
depend on other factors. Unlike the variant locations of human ets proteins, we find 
that the chicken ets gene product is equally distributed between the cytoplasmic and 
nuclear subcellular fractions; this observation would seem to be consistent with the 
known genetic organization of both ets domains in the avian It is possible, 
too, that the avian ets protein, in response to some physiological event, shuttles between 
the cytoplasm and nucleus, whereupon each domain is able to exert its distinctive 
activity. 
Both ers-1 and ets-2 domains may be of potential interest in oncology. The 
transposition of these genes in nonrandom translocations found in specific leukemias, 
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as well as in their associated altered expression, suggests that both ets-1 and ets-2 
genes may be involved in human hematopoietic n e ~ p l a s i a s . ~ ~  Differential expression of 
ets proteins could provide useful molecular markers for the characterization of 
hematopoietic tumors. 
Having established that the human genome contains two distinct loci with 
homology to the viral ets gene, Hu-efs-1 and Hu-efs-2, made it possible to precisely 
map their locations onto their respective human chromosomes. Employing both 
somatic cell hybrid studies and in-situ chromosomal techniques, we have localized the 
human proto-ets-1 and proto-ets-2 domains to the human chromosomes, 1 lq23 and 
21q22, 
A number of leukemias of myelomonocytic lineage show chromsome abnormalities 
in the very region where the human ets loci reside. In fact, the 1 lq23 region where the 
Hu-ets-1 locates is known to be involved in a number of translocations associated with 
acute myeloid leukemias. We have, therefore, focused primarily on the 
t(4;l l)(q21;q23) translocation, an aberration that is associated with a rare infant 
leukemia of the undifferentiated type (AUL) thought to be congenital, and could 
perhaps involve the Hu-ets-1 locus. Similarly, we investigated the t(8;21)(q22;q22) 
translocation, associated with a subtype of acute myelogenous leukemia (AML-M2) 
involving the 21q22 chromosomal region, where Hu-ets-2 is located (FIG. 1 I ) .  
FIGURE 11. Partial karyotype analysis showing the normal and 
recombinant chromosomes resulting from: (A) the reciprocal 
translocation t(4;l l)(q21;q23), and (B) the reciprocal transloca- 
tion t(8;21)(q22;q22). 
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From Southern blot studies using genomic DNA samples derived from cell hybrids 
containing the recombinant chromosomes derived from these translocations, we have 
found that the Hu-ets- 1 gene does in fact translocate from chromosome 1 1 to 4, while 
the Hu-ets-2 gene was found to transpose from chromosome 21 to 8.” Using in-situ 
hybridization, other workers have shown, with gene probes for y-interferon and v-ets 
by hybridizing them to metaphase chromosomes obtained from three patients with 
AML having the chromosomal translocation t(9;l l)(p22;q23), that the proto-ets-1 
gene was translocated from chromosome 1 1 to the short arm of chromosome 9 adjacent 
to the interferon genes.28 Such studies reinforce the supposition that juxtapositioning of 
the proto-ets genes next to other cellular genes may lead to their dysregulation. 
Further, the translocations we have observed appear to affect the transcription 
patterns of both Hu-ets genes; these were confirmed by Northern blot studies on RNA 
derived from leukemic and control samples, as well as from continuous cell lines 
derived from patients. In  such comparative studies, albeit on limited samples, we have 
found that in t (4; l l )  leukemic cells significantly lower levels of Hu-ets-1 mRNA were 
present. Similarly, studies on t(8;21) AML samples revealed that not all the species of 
Hu-ets-2 mRNA known to be present in normal lymphocytes and other human cells 
were present. Particularly absent, or markedly reduced, was the larger 4.7-kb species 
of human ets-2 mRNA, suggesting that this alteration of expression of human ets 
mRNA in leukemia patient samples may arise as a consequence of the specific position 
effects sustained (FIG. 12). 
The significance of these studies and their specificity was further reinforced by 
utilizing our Hu-ets-l probe to show that the ets-l gene was not transposed in the 
(1 1;22)(q12;q23) translocation of Ewing sarcoma, in contrast to the (4; l l )  transloca- 
tion noted previously. However, in neither case was there any evidence that the human 
ets-1 or ets-2 genes were rearranged, although the precise breakpoints and their 
location relative to these proto-oncogenes remains to be determined. Such proto-ets 
gene relocations may well play a critical role in altering the regulation of these unique 
genes for certain specific leukemias; any altered products arising from such transloca- 
tions may serve as useful diagnostic or prognostic markers in these specific patholo- 
g i e ~ . ’ ~  
The 21q22 region or, specifically, the 21q22.3 region, where Hu-ets-2 has been 
physically and genetically mapped, seems to be relevant not only to cancer but to other 
human cytogenetic pathologies as well. This region is the precise region that when 
trisomic appears to confer the Down’s syndrome (DS). DS afflicts 1 out of 600 
newborns, and such individuals display a number of dimorphic features and develop- 
mental abnormalities, including mental retardati~n.~’ The causes of trisomy of the 
21q22.3 region are mainly due to the trisomy of the entire chromosome 21. Very rarely, 
but significantly, a microduplication of the q22.3 region or inheritance of this region 
attached to an autosome (partial trisomy) may be the cause of the DS phenotype. Such 
rare individuals, therefore, may prove to be very informative for defining the minimal 
genetic region required for the appearance of DS. Since we know that the Hu-efs-2 
gene locates in this region, studies with this probe may become quite valuable for the 
initiation of molecular cloning studies necessary to identify and isolate the entire 
region responsible for DS. Furthermore, preliminary data shows three copies of the 
ets-2 gene in some of these rare DS patients using an ets-2-specific probe cloned in our 
laboratory.” Significantly, DS patients show a higher incidence of leukemia, as well as 
precocious neurological signs of Alzheimer’s disease.” Having a specific antibody for 
the human ets-2 proteins available will permit us to evaluate and precisely quantitate 
the expression of this gene in both Down’s syndrome and Alzheimer’s disease. 
Finally, restriction fragment-length polymorphisms (RFLPs) for the ets-2 gene 
have been used as genetic markers to study whether or not the genetic constitution 
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FIGURE 12. Northern blot analysis of total RNA extracted from: (A) blast cells derived from a 
t(4;I 1 )  AUL patient and normal lymphocytes (N.L.), and (B) blast cells derived from two 
t(8;21) AML-M2 patients and normal lymphocytes. In all cases, total RNA was extracted by the 
guanidinium/cesium chloride method and was resolved on 1.2% formaldehyde-agarose gels. 
Hybridization was performed under stringent conditions (2b) with: (A) ets-1 (RD6K) and (B) 
ers-2 (H33) probes. The same blots (borrom) were rehybridized using an a-actin cDNA probe in 
order to compare relative amounts of RNA in these samples. 
(haplotype) of the chromosome 21 that undergoes normal, meiotic disjunction is 
different from the haplotype of chromosome 21 that is not undergoing disjunction and 
therefore predisposing to the trisomy associated with Down’s syndrome. The results of 
our extensive survey with the Hu-ets-2 probe, performed on families with a Down’s 
syndrome child, shows that all examples of chromosome 21 are genetically similar, 
thus indicating that haplotype analysis of chromosome 21 is not applicable to the 
190 ANNALS NEW YORK ACADEMY OF SCIENCES 
prevention of this syndrome.” This finding is important since on the basis of a previous 
study the clinical relevance of similar chromosomal haplotype tests was suggested.” 
According to our experience, such tests should be viewed with extreme caution and 
reservation. 
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